HAMILTON, Bermuda, Nov. 10 /PRNewswire-FirstCall/ -- Warner Chilcott Limited announced today that it has revised the release date for its third quarter 2006 financial results. Third quarter results will be released prior to the market opening on Tuesday, November 14, 2006 followed by an investor conference call the same day at 8:00 AM (Eastern Time) to review the results. To participate in the call, please dial (877) 809-2546 in the United States and Canada or (706) 634-9509 internationally, and ask to join the Warner Chilcott Third Quarter Earnings conference call, conference ID number 1929762. A recording will be available two hours following the call through midnight (Eastern Time) November 28, 2006 that can be replayed by calling (800) 642-1687 within the United States and Canada or (706) 645-9291 internationally.
The Company
Warner Chilcott is a leading specialty pharmaceutical company focused on marketing, selling, developing and manufacturing branded prescription products in women’s healthcare and dermatology in the United States. WCRX-F
Warner Chilcott Limited
CONTACT: Paul Herendeen, Chief Financial Officer of Warner ChilcottLimited, +1-973-442-3200, pherendeen@wcrx.com
Web site: http://www.warnerchilcott.com/
